[Remote] Senior Director - Gene Therapy Medical Affairs at Eli Lilly and Company

Chester, Maryland, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

PharmD or PhD in a medically/scientifically related field with 8+ years of relevant industry experience, or Master level degree with 10+ years of industry experience in relevant therapeutic area
Experience in Medical Affairs or Patient Advocacy
Experience in genetics, gene therapy, or rare disease

Responsibilities

Serve as a scientific expert staying abreast of new advances in relevant therapeutic areas and collaborate with cross-functional teams in the development of gene therapy medical and launch strategies
Develop and maintain relationships with thought leaders, patient organization leaders, and external experts to identify emerging trends and opportunities, providing scientific and medical education
Provide scientific support and training, gene therapy education, and help to remove site-specific obstacles at gene therapy administration sites
Collect and disseminate meaningful clinical insights to inform medical, patient advocacy, and commercial strategies and initiatives
Work collaboratively on initiatives to educate and inform healthcare professionals, patients, and families about genetic testing and gene therapy
Develop and review medical and scientific content for presentations and provide education to internal teams and external stakeholders
Support clinical trials through trial awareness initiatives and providing medical and patient insights
Execute the role in a compliant manner, adhering to all governing internal and external requirements, procedures, and laws, demonstrating good judgement at all times

Skills

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free